Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action. Lantern also rescues and revitalizes abandoned or failed cancer drugs using machine learning techniques, genomic data, and precision oncology trials. Lantern Pharma embraces emerging technologies that can help transform the pace and insight of oncology drug development.